Literature DB >> 17478871

Concentrations of methadone in breast milk and plasma in the immediate perinatal period.

Lauren M Jansson1, Robin E Choo, Cheryl Harrow, Martha Velez, Jennifer R Schroeder, Ross Lowe, Marilyn A Huestis.   

Abstract

This study evaluates concentrations of methadone in breast milk and plasma among a sample of methadone-maintained women in the immediate perinatal period. Twelve methadone-maintained, lactating women provided blood and breast milk specimens 1, 2, 3, and 4 days after delivery. Specimens were collected at the time of trough (just before methadone dose) and peak (3 hours after dosing) maternal methadone levels. Paired specimens of foremilk (prefeed) and hindmilk (postfeed) were obtained at each sampling time. Although there was a significant increase in methadone concentration in breast milk over time for the peak postfeed sampling time, t (22)=2.40, P=.0255, methadone concentrations in breast milk were small, ranging from 21 to 314 ng/mL, and were unrelated to maternal methadone dose. Results obtained from this study contribute to the recommendation of breastfeeding for methadone-maintained women regardless of methadone dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478871      PMCID: PMC2718050          DOI: 10.1177/0890334407300336

Source DB:  PubMed          Journal:  J Hum Lact        ISSN: 0890-3344            Impact factor:   2.219


  35 in total

1.  The use of plasma levels to optimize methadone maintenance treatment.

Authors:  N Loimer; R Schmid
Journal:  Drug Alcohol Depend       Date:  1992-08       Impact factor: 4.492

2.  Methadone assays in pregnant women and progeny.

Authors:  G Blinick; C E Inturrisi; E Jerez; R C Wallach
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

3.  High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.

Authors:  John J McCarthy; Martin H Leamon; Michael S Parr; Barbara Anania
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

4.  Methadone levels in human milk.

Authors:  J J McCarthy; B L Posey
Journal:  J Hum Lact       Date:  2000-05       Impact factor: 2.219

Review 5.  Medical complications in methadone patients.

Authors:  M J Kreek
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

6.  Pregnancy and addiction. A comprehensive care model.

Authors:  L M Jansson; D Svikis; J Lee; P Paluzzi; P Rutigliano; F Hackerman
Journal:  J Subst Abuse Treat       Date:  1996 Jul-Aug

7.  Breastfeeding rates in the United States by characteristics of the child, mother, or family: the 2002 National Immunization Survey.

Authors:  Ruowei Li; Natalie Darling; Emmanuel Maurice; Lawrence Barker; Laurence M Grummer-Strawn
Journal:  Pediatrics       Date:  2004-12-03       Impact factor: 7.124

Review 8.  Physiological basis of longitudinal changes in human milk yield and composition.

Authors:  P E Hartmann; C G Prosser
Journal:  Fed Proc       Date:  1984-06

Review 9.  Methadone maintenance and lactation: a review of the literature and current management guidelines.

Authors:  Lauren M Jansson; Martha Velez; Cheryl Harrow
Journal:  J Hum Lact       Date:  2004-02       Impact factor: 2.219

10.  Methadone disposition during the perinatal period in humans.

Authors:  M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  1979       Impact factor: 3.533

View more
  17 in total

1.  Disparities in breastfeeding outcomes among women with opioid use disorder.

Authors:  Julia M Stephen; Shikhar Shrestha; Elizabeth Yakes Jimenez; Sonnie M Williams; Alyssa Ortega; Sandra Cano; Lawrence Leeman; Ludmila N Bakhireva
Journal:  Acta Paediatr       Date:  2019-12-09       Impact factor: 2.299

2.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

3.  Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

Authors:  Debra L Bogen; James M Perel; Joseph C Helsel; Barbara H Hanusa; Matthew Thompson; Katherine L Wisner
Journal:  Breastfeed Med       Date:  2011-02-24       Impact factor: 1.817

4.  Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial.

Authors:  Michelle Tuten; Heather Fitzsimons; Margaret S Chisolm; Paul A Nuzzo; Hendree E Jones
Journal:  Addiction       Date:  2012-06-21       Impact factor: 6.526

Review 5.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

6.  Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Authors:  Teresa R Gray; Robin E Choo; Marta Concheiro; Erica Williams; Andrea Elko; Lauren M Jansson; Hendreé E Jones; Marilyn A Huestis
Journal:  Addiction       Date:  2010-09-20       Impact factor: 6.526

7.  The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.

Authors:  Hendrée E Jones; Lauren M Jansson; Kevin E O'Grady; Karol Kaltenbach
Journal:  Neurotoxicol Teratol       Date:  2013 Sep-Oct       Impact factor: 3.763

8.  ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.

Authors:  Lauren M Jansson
Journal:  Breastfeed Med       Date:  2009-12       Impact factor: 1.817

9.  Maternal methadone dosing schedule and fetal neurobehaviour.

Authors:  Lauren M Jansson; Janet A Dipietro; Martha Velez; Andrea Elko; Heather Knauer; Katie T Kivlighan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-01

10.  Methadone maintenance and long-term lactation.

Authors:  Lauren M Jansson; Robin Choo; Martha L Velez; Ross Lowe; Marilyn A Huestis
Journal:  Breastfeed Med       Date:  2008-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.